Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-106923
Filing Date
2025-04-30
Accepted
2025-04-30 14:50:47
Documents
4
Period of Report
2025-04-30

Document Format Files

Seq Description Document Type Size
1 6-K d935542d6k.htm 6-K 9022
2 EX-99.1 d935542dex991.htm EX-99.1 16978
3 GRAPHIC g935542g0410004833066.jpg GRAPHIC 2601
4 GRAPHIC g935542logo.jpg GRAPHIC 2140
  Complete submission text file 0001193125-25-106923.txt   34031
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 25894081
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)